CompletedNot Applicable

Executive Functioning and Sleep Fragmentation in COVID-19 Patients

Italy76 participantsStarted 2020-06-12

Plain-language summary

This project aims to investigate executive functioning abilities (primary outcome) and quality of sleep (secondary outcome) in patients with COVID-19 (while distinguishing between those with and without sleep fragmentation), compared with an age- and education matched control group of healthy individuals who did not experience contagion. Prefrontal electrical activity will be recorded with EEG in patients, and related to sleep and cognitive-executive metrics. The main questions it aims to answer are: * is executive functioning impaired in COVID-19 patients compared with individuals who were not infected? * is there a relationship between altered sleep and impaired executive functioning in COVID-19 patients? * is such relationship related to altered prefrontal brain activitity in COVID-19 patients?

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * For patients: current contagion from COVID-19 * For patients and controls: * age\>18 years * absence of clinical conditions, cognitive and sensory deficits, and severe psychiatric disorders that would impair participation in research identified through clinical history. Exclusion Criteria: * current or past neuro-psychiatric disorder * current or past sleep disorder

What they're measuring

Executive/Inhibitory skills

Timeframe: Assessment day

Trial details

NCT IDNCT05764096

SponsorIstituti Clinici Scientifici Maugeri SpA

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-31

View on ClinicalTrials.gov More COVID-19 trials